Seeing Is Believing
Currently out of the existing stock ratings of Mohan Naidu, 67 are a BUY (95.71%), 3 are a HOLD (4.29%).
Analyst Mohan Naidu, currently employed carries an average stock price target met ratio of 83.37% that have a potential upside of 31.48% achieved within 556 days.
Mohan Naidu’s has documented 149 price targets and ratings displayed on 12 stocks. The coverage was on Healthcare, Technology sectors.
Most recent stock forecast was given on TDOC, Teladoc at 25-Oct-2023.
Analyst best performing recommendations are on TRHC (TABULA RASA HEALTHCARE).
The best stock recommendation documented was for OMCL (OMNICELL) at 10/26/2018. The price target of $73 was fulfilled within 12 days with a profit of $8.5 (13.18%) receiving and performance score of 10.98.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$120
$21.9 (22.32%)
$100
8 days ago
(13-Nov-2024)
10/13 (76.92%)
$25.2 (26.58%)
85
Buy
$105
$6.9 (7.03%)
$105
2 months 1 days ago
(20-Sep-2024)
15/18 (83.33%)
$25.47 (32.03%)
199
Buy
$103
$4.9 (4.99%)
$88
2 months 17 days ago
(04-Sep-2024)
15/16 (93.75%)
$20.34 (24.61%)
190
Buy
$92
$-6.1 (-6.22%)
$92
2 months 17 days ago
(04-Sep-2024)
11/11 (100%)
$9.34 (11.30%)
249
Buy
$110
$11.9 (12.13%)
$107
5 months 1 days ago
(20-Jun-2024)
4/8 (50%)
$27.74 (33.72%)
677
What Year was the first public recommendation made by Mohan Naidu?